Time for military to get real about risks of anti-malaria drug

The American, Australian, British, French and German militaries moved off mefloquine, but stubbornly the Canadian Armed Forces are not doing so.

Members of the Canadian military deserve better than to be give an anti-malaria drug with dangerous side-effects when alternatives are available, write Amir Attaran, Michel Drapeau, and Pat Stogran. The Hill Times photograph by Jake Wright

Opinion

BY MICHEL DRAPEAU, AMIR ATTARAN, PAT STOGRAN

March 13, 2017

OTTAWA—The Canadian Armed Forces are excellent at many things, but tropical medicine is definitely not one of them. For months now, over the rising howls of veterans and scientists, the CF has obstinately refused to reconsider its plans to use a controversial malaria medicine, mefloquine, which i...

To keep reading, subscribe and become a political insider.

Only $7.76 a week for an annual subscription.

Enjoy unlimited website access and the digital newspaper.

Cancel anytime.

Already a Subscriber?

Get Weekend Point of View Newsletter

A round up of the past weekâ€™s opinion writers and columnists on Saturdays and Sundays.

By entering your email address you consent to receive email from The Hill Times containing news, analysis, updates and offers. You may unsubscribe at any time. See our privacy policy